Exane Derivatives’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History
Bought
Maintained
Sold
Other funds holding BIV
Exane Derivatives's BIV Position: Q2 2022 in Review
Exane Derivatives sold out of Vanguard Intermediate-Term Bond ETF (BIV) in Q2 2022, closing a stake of 750 shares — an estimated $61.4K sold.
Exane Derivatives first reported a position in BIV in Q2 2021 and held it in 3 quarters. The position peaked at $67.6K in Q2 2021. 673 funds tracked by Wall St. Rank hold BIV as of Q2 2022.
- Exane Derivatives reported no remaining Vanguard Intermediate-Term Bond ETF position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 750 Vanguard Intermediate-Term Bond ETF shares in Q2 2022, an estimated $61.4K.
- Exane Derivatives first reported a position in Vanguard Intermediate-Term Bond ETF in Q2 2021 and held it in 3 quarters.
- Exane Derivatives's Vanguard Intermediate-Term Bond ETF position peaked at $67.6K in Q2 2021.
- 673 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.